258. Phase I/IIa Study of TT-034, a DNA-Directed RNA Interference (ddRNAi) Agent Delivered as a Single Administration for the Treatment of Subjects with Chronic Hepatitis C Virus (HCV)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Patel, K; Kilfoil, G; Wyles, DL; Naggie, S; Lawitz, E; Bradley, S; Lindell, P; Suhy, D

Published Date

  • May 2016

Published In

Volume / Issue

  • 24 /

Start / End Page

  • S102 - S102

International Standard Serial Number (ISSN)

  • 1525-0016

Digital Object Identifier (DOI)

  • 10.1016/S1525-0016(16)33067-2